No headlines found.
Pro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month Results
ACCESSWIRE (Thu, 8-Feb 4:01 PM ET)
Pro-Dex Inc is engaged in designing, developing, and manufacturing powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. In addition, the company provides engineering consulting and placement services, as well as quality and regulatory consulting services. Most of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.
Pro-Dex trades on the NASDAQ stock market under the symbol PDEX.
As of April 24, 2024, PDEX stock price declined to $18.50 with 4,522 million shares trading.
PDEX has a market cap of $64.96 million. This is considered a Micro Cap stock.
Last quarter Pro-Dex reported $13 million in Revenue and $.14 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.21.
In the last 3 years, PDEX stock traded as high as $38.45 and as low as $12.40.
The top ETF exchange traded funds that PDEX belongs to (by Net Assets): VTI, VXF, DFAS, IWC, DFAC.
PDEX has underperformed the market in the last year with a return of +13.8%, while the SPY ETF gained +24.1%. In the last 3 month period, PDEX fell short of the market, returning -13.3%, while SPY returned +4.5%. However, in the most recent 2 weeks PDEX has outperformed the stock market by returning +1.9%, while SPY returned -1.7%.
PDEX support price is $18.05 and resistance is $19.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PDEX stock will trade within this expected range on the day.